Over the last 90 days, prior to the date of this filing, there have been 41 insider transactions reported to the SEC for Incyte. These transactions came from the activities of 17 separate insiders that resulted in a net acquisition of 33 company shares. Relative to the preceding 90-day window of time, there were 24 transactions from 12 insiders which resulted in the net acquisition of 51,292 shares.
This is below the average for insider transactions in the 207-company Biotechnology & Medical Research peer group over the last 90-day period. Activity in the peer group averaged 45.9 transactions per company, with company insiders acquiring on average 31,111 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/879169/000120919120009349/xslF345X03/doc4.xml
|Analysts Trim Janus Henderson Group's Q1, 2020, and ...|
|Johnson & Johnson's 2020 and 2021 Earnings Estim...|
|2021 Earnings Projection for John Bean Technologies ...|
|Johnson Controls International's Q2, 2020, and 2021 ...|
|2020, 2021 Earnings Estimates for JB Hunt Transport ...|